In vitro functional assays demonstrated that the decreased secretory and antigen-presenting function was universally observed in pDCs of SLE patients and At-Risk individuals, independently of the IFN activity in their PBMCs. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.